Tag: Enveda

Enveda Raises $150M Series D Funding to Reach Unicorn Status, Enrolls First Patient in Lead Program, and Adds Mikael Dolsten to Board of Directors

Enveda Raises $150M Series D Funding to Reach Unicorn Status, Enrolls First Patient in Lead Program, and Adds Mikael Dolsten to Board of Directors

Pipeline expansion: Company advances first-in-class clinical pipeline to address large unmet medical needs in Atopic Dermatitis, Asthma, Inflammatory Bowel Disease, and Obesity Platform scale: Company doubles down on its platform, delivering 12+ development candidates from…

Read More Read More

Enveda Gains Backing from Sanofi to Advance AI-Driven Drug Discovery to Clinical Trials Bringing Total Series C Financing to $150M

Enveda Gains Backing from Sanofi to Advance AI-Driven Drug Discovery to Clinical Trials Bringing Total Series C Financing to $150M

February 26, 2025 09:00 AM Eastern Standard Time BOULDER, Colo.–(BUSINESS WIRE)–Enveda, a leading biotechnology company harnessing life’s chemistry to discover better medicines, today announced an investment from Sanofi, a leading healthcare company. This investment reaffirms the…

Read More Read More

Enveda Closes $130M Series C Funding to Deliver Multiple Clinical Readouts from a Pipeline of 10 Development Candidates

Enveda Closes $130M Series C Funding to Deliver Multiple Clinical Readouts from a Pipeline of 10 Development Candidates

Kinnevik, FPV, Premji Invest, Lingotto Innovation, and Baillie Gifford back leading biotech applying ML, metabolomics, and automated laboratory workflows to deliver candidate medicines 4X faster than industry average Enveda pipeline consists of multiple first-in-class and…

Read More Read More